by GlobeNewsWire | Sep 13, 2016 | Globe Newswire
Brooklyn, NY, Sept. 13, 2016 (GLOBE NEWSWIRE) — The first section of the report presents an overview of induced pluripotent stem cells. This section encapsulates the specifications, definition, and classification of induced pluripotent stem cells. Pluripotent...
by GlobeNewsWire | Sep 12, 2016 | Globe Newswire
CLEVELAND, Sept. 12, 2016 (GLOBE NEWSWIRE) — Athersys, Inc. (Nasdaq:ATHX) announced today the successful completion of Japan’s Pharmaceutical and Medical Devices Agency (PMDA) review of the Clinical Trial Notification (CTN), allowing the commencement by HEALIOS...
by GlobeNewsWire | Sep 9, 2016 | Globe Newswire
HOUSTON, Sept. 09, 2016 (GLOBE NEWSWIRE) — Spine Injury Solutions, Inc. (OTCQB:SPIN), a technology-driven, medical service, device and healthcare solution company servicing the multi-billion dollar spine injury sector, through its Chairman/CEO Dr. William...
by GlobeNewsWire | Sep 8, 2016 | Globe Newswire
RANCHO CORDOVA, Calif., Sept. 08, 2016 (GLOBE NEWSWIRE) — Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that Michael Bruch, Cesca’s Chief Financial Officer, and Dalip Sethi, Ph.D., Director of...
by GlobeNewsWire | Sep 8, 2016 | Globe Newswire
SAN DIEGO, Sept. 08, 2016 (GLOBE NEWSWIRE) — Poseida Therapeutics, Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, announced the creation of the company’s scientific advisory...